510(k) Report

510(k) · Cleared

Cleared

NT Meditens Plus, Type 290

K014020510(k) TraditionalCleared Jul 11, 2002217-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Medical Research, Ltd. · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Jul 11, 2002 after a 217-day review. The FDA summary names its predicate without a number. 15 later devices descend from it.

Decided
Jul 11, 2002
Review
217 days
Class
Class II
Product code
GZJ
Recalls
None
Predicates
0

15 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared2020: 2 descendants cleared2011: 1 descendant cleared2012: 1 descendant cleared2015: 1 descendant cleared2019: 1 descendant cleared2016: 1 descendant cleared2021: 3 descendants cleared2023: 1 descendant cleared2024: 1 descendant cleared2022: 2 descendants cleared200020052010201520202025
  1. This deviceK014020 NT Meditens Plus, Type 290Bio-Medical Research, Ltd. · 2002
  2. Descendant · cites it directly · 14 of its ownK082011 Medistim XP, Type 281 and Meditens XP, Type 458Bio-Medical Research, Ltd. · 2008
  3. Descendant · 2 generations on · 9 of its ownK110350 Kneehab XPBio-Medical Research, Ltd. · 2011
  4. Descendant · 2 generations on · 7 of its ownK150413 QB1 System Powered Muscle Stimulator & Transcutaneous Electrical…Cymedica Orthopedics, Inc. · 2015
  5. Descendant · 3 generations on · 4 of its ownK163067 CyMedica e-vive™ System; CY-1000Cymedica Orthopedics, Inc. · 2016
  6. Descendant · 2 generations on · 2 of its ownK193275 Nerve and Muscle StimulatorShenzhen Xft Medical Limited · 2020

Showing 5 of 15 descendants. See all descendants

Descendants cleared per year

2008: 12011: 12012: 12015: 12016: 12019: 12020: 22021: 32022: 22023: 12024: 1
2008high 3 (2021) · low 0 (2009)2026

Most influential descendants

Showing 5 of 15 · See all
  • K082011Medistim XP, Type 281 and Meditens XP, Type 458Bio-Medical Research, Ltd. · 2008 · cites it directly14descendants
  • K110350Kneehab XPBio-Medical Research, Ltd. · 2011 · 2 generations on9descendants
  • K150413QB1 System Powered Muscle Stimulator & Transcutaneous Electrical Nerve StimulatorCymedica Orthopedics, Inc. · 2015 · 2 generations on7descendants
  • K163067CyMedica e-vive™ System; CY-1000Cymedica Orthopedics, Inc. · 2016 · 3 generations on4descendants
  • K193275Nerve and Muscle StimulatorShenzhen Xft Medical Limited · 2020 · 2 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K014020NT Meditens Plus, Type 290Bio-Medical Research, Ltd.2002—
+1K082011Medistim XP, Type 281 and Meditens XP, Type 458Bio-Medical Research, Ltd.2008—
+2K110350Kneehab XPBio-Medical Research, Ltd.2011—
+2K150413QB1 System Powered Muscle Stimulator & Transcutaneous Electrical Nerve…Cymedica Orthopedics, Inc.2015—
+3K163067CyMedica e-vive™ System; CY-1000Cymedica Orthopedics, Inc.2016—
+2K193275Nerve and Muscle StimulatorShenzhen Xft Medical Limited2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201110
201210
201510
201610
201910
202020
202130
202220
202310
202410
FIG. 1 — Lineage of K014020, 2002–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

  1. #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Promax
Named without a submission number
—

What descends from it? (15)

See all 15

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K082011Medistim XP, Type 281 and Meditens XP, Type 458Bio-Medical Research, Ltd.200814

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K082011 (Bio-Medical Research, Ltd., 2008) has gone furthest, with 14 descendants of its own.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GZJ

1in 2025

2007: 132008: 112009: 162010: 52011: 52012: 122013: 22014: 42015: 32016: 32017: 32018: 22019: 32020: 42021: 32022: 42023: 12024: 32025: 12026 (partial year): 2
2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007: 223 days median2008: 136 days median2009: 155 days median2010: 232 days median2011: 168 days median2012: 154 days median2014: 344 days median2015: 202 days median2016: 163 days median2017: 113 days median2019: 156 days median2020: 183 days median2021: 231 days median2022: 175 days median2024: 207 days median
2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007: 42008: 12011: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007: 42008: 452009: 172010: 222011: 222012: 202013: 102014: 232015: 182016: 322017: 582018: 212019: 72020: 102021: 52022: 42023: 392024: 122025: 13
2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071322344
200811136145
200916155017
20105232022
20115168122
201212154020
20132—010
20144344023
20153202018
20163163032
20173113058
20182—021
2019315607
20204183010
2021323105
2022417504
20231—039
20243207012
20251—013
20262—0—

What is it indicated for?

The MediTENS PLUS is indicated for:

The symptomatic relief and management of chronic intractable pain. It is also an adjunctive treatment in the management of post-surgical and posttraumatic pain. The device has no curative value and should only be used in conjunction with Medical supervision.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K014020: NT Meditens Plus, Type 290.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K014020

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026